Comparative quantitative analysis of SARS-CoV-2 Spike neutralizing antibody titers following two anti COVID-19 vaccines in India
GV, C.; Srikantam, A.
Show abstract
In COVID 19 Pandemic,first line of defence is effective vaccination program.Because of multiple platforms available for vaccine production we tested relative immunogenicity of two vaccines available in India, Covaxin(R) and Covishield(R) We performed quantitative analysis of neutralizing antibodies to SARS Cov2 spike (receptor binding domain) protein, from sera of 53 subjects who completed vaccines schedules.There was significantly higher immunogenic response with Covishield(R) as compared to Covaxin(R) and are independent of age. Studies on a large scale with long term follow up are needed to further advance the knowledge in this domain.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV-2 seroprevalence in Delhi, India - September-October 2021 – a population based seroepidemiological study 94%
- Breakthrough infection with SARS-CoV-2 and its predictors among healthcare workers in a medical college and hospital complex in Delhi, India 93%
- Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variant 93%
Similar papers in this journal
- Immunogenicity and safety of Biological Es CORBEVAX vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD or COVAXIN: A Prospective double-blind randomised phase III clinical study 95%
- Clinical outcomes in vaccinated individuals hospitalized with Delta variant of SARS-CoV-2 93%
- The Global case-fatality rate of COVID-19 has been declining disproportionately between top vaccinated countries and the rest of the world 92%
Similar papers in this journal
- Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naïve adult Nigerians 95%
- Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of Confidence, Convenience, and Complacency; A Cross-sectional study 95%
- Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches 95%
Similar papers in this journal
- COVID-19 Vaccine hesitancy in Addis Ababa, Ethiopia: A mixed-methods study 95%
- Adenovirus and RNA-based COVID-19 vaccines: perceptions and acceptance among healthcare workers 92%
- Protocol for a prospective, hospital-based registry of pregnant women with SARS-CoV-2 infection in India: PregCovid Registry study 91%
Similar papers in this journal
- Assessment of the knowledge, preferences and concern regarding the prospective COVID- 19 vaccine among adults residing in New Delhi, India-A cross sectional study 97%
- COVID-19 Vaccination-Infection Status And Immunological Profile: Identification Of High Risk Population For Targeted Booster Immunization In India 94%
- Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.